{"meta":{"query_hash":"ac2bfcb93da8","filters":{"venue":"Experimental Hematology and Oncology"},"cohort_total":26,"direct_labels_cover":0,"predictions_cover":26,"exported":26,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/ac2bfcb93da8","api":"https://metacan.xera.ac/api/v1/cohort?venue=Experimental+Hematology+and+Oncology"},"results":[{"id":"W2096261897","doi":"10.1186/2162-3619-2-32","title":"Everolimus and sunitinib for advanced pancreatic neuroendocrine tumors: a matching-adjusted indirect comparison","year":2013,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Sunitinib; Medicine; Everolimus; Neuroendocrine tumors; Pancreatic neuroendocrine tumor; Internal medicine; Hematology; Oncology; Matching (statistics); Pathology; Cancer","score_opus":0.0363331061368733,"score_gpt":0.37481042835918443,"score_spread":0.33847732222231114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096261897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893883,0.0052737794,0.000021288894,0.0021442948,0.00013894674,0.0018230557,0.000006855975,0.000115128205,0.0010883795],"genre_scores_gemma":[0.99436516,0.00012618159,0.0029421619,0.0010551257,0.000059383838,0.00096863107,0.000030736228,0.000039698756,0.0004129198],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981416,0.00016838954,0.00043294675,0.0004968531,0.00012679904,0.0006334493],"domain_scores_gemma":[0.99858415,0.00068089226,0.00014097856,0.00020394924,0.00006437454,0.00032564934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006131824,0.00027200952,0.0010025954,0.00017470829,0.00018461168,0.000018242263,0.00009332358,0.000028850614,0.0002014287],"category_scores_gemma":[0.0001590426,0.00023908097,0.000058530615,0.00010764417,0.00045826368,0.00017981815,0.0001623072,0.00031564085,0.000029519599],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022091119,0.008917592,0.266708,0.0038129527,0.0009704069,0.020982865,0.0065559135,0.000010736852,0.5728032,0.03463808,0.017728228,0.04478088],"study_design_scores_gemma":[0.027435046,0.022732457,0.031498544,0.00029398227,0.00019320748,0.09346554,0.012611927,0.0008374893,0.791053,0.0034289516,0.015620858,0.0008289744],"about_ca_topic_score_codex":0.00007396284,"about_ca_topic_score_gemma":0.00003341467,"teacher_disagreement_score":0.23520945,"about_ca_system_score_codex":0.0000671117,"about_ca_system_score_gemma":0.00006893879,"threshold_uncertainty_score":0.9749439},"labels":[],"label_agreement":null},{"id":"W2099215382","doi":"10.1186/2162-3619-2-20","title":"Optimization of cytarabine (ARA-C) therapy for acute myeloid leukemia","year":2013,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Canadian Cancer Society Research Institute","keywords":"Cytarabine; Medicine; Myeloid leukemia; Leukemia; Pharmacology; Myeloid; Internal medicine; Oncology","score_opus":0.021737496306857704,"score_gpt":0.3558260449127454,"score_spread":0.33408854860588766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099215382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854863,0.0044726734,0.0027401524,0.0023858096,0.00017075147,0.0018031044,0.000008233233,0.00005125542,0.0028816778],"genre_scores_gemma":[0.96591336,0.0007580616,0.030577943,0.0011586422,0.000083075494,0.00064821815,0.000083891435,0.00003139614,0.0007453891],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884313,0.000071545095,0.00035068305,0.00030465436,0.000097027696,0.00033295967],"domain_scores_gemma":[0.99920744,0.00020545183,0.000117212694,0.0002003674,0.0001286996,0.0001408221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013320638,0.00016841773,0.00062179955,0.0001335831,0.000089562454,0.000005300774,0.00009861128,0.00033047737,0.0008103604],"category_scores_gemma":[0.00003175885,0.000137761,0.00008082808,0.00010423806,0.0004353677,0.00010418751,0.00006898488,0.00017497556,0.000029070434],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010687698,0.0021240488,0.010141273,0.000261844,0.0016214916,0.00018897475,0.0039363513,0.00014994509,0.87764925,0.02690995,0.041435417,0.024893787],"study_design_scores_gemma":[0.01411206,0.0074298587,0.0016437266,0.000030852607,0.00007634569,0.001944512,0.0012441973,0.010049052,0.9573076,0.0004041672,0.0055185226,0.00023910741],"about_ca_topic_score_codex":0.00006995398,"about_ca_topic_score_gemma":0.0000017900278,"teacher_disagreement_score":0.07965838,"about_ca_system_score_codex":0.00033416657,"about_ca_system_score_gemma":0.00032511007,"threshold_uncertainty_score":0.8872878},"labels":[],"label_agreement":null},{"id":"W2103118894","doi":"10.1186/2162-3619-1-12","title":"Expansion of hematopoietic stem cells for transplantation: current perspectives","year":2012,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; National Institutes of Health","keywords":"Haematopoiesis; Stem cell; Hematology; Transplantation; Medicine; Bone marrow; Hematopoietic stem cell transplantation; Immunology; Hematopoietic stem cell; Genetic enhancement; Cancer research; Biology; Internal medicine; Gene; Cell biology; Genetics","score_opus":0.03408724952600803,"score_gpt":0.35048768365288413,"score_spread":0.31640043412687613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103118894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96498126,0.028279433,0.0037756264,0.00020034377,0.0006124781,0.00087706436,0.000018228711,0.00004169545,0.0012138734],"genre_scores_gemma":[0.9961199,0.0005498468,0.0029488814,0.000058316244,0.00007764432,0.00015644285,0.000024652903,0.000018927327,0.000045374443],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887866,0.00008058593,0.0003916075,0.00023719578,0.000111587426,0.00030039102],"domain_scores_gemma":[0.9992488,0.00028559196,0.00012243973,0.00012997683,0.000054490898,0.00015872602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018768053,0.00016745721,0.0005388952,0.00010080573,0.00007537875,0.0000021748158,0.00004431647,0.00018758686,0.00013095875],"category_scores_gemma":[0.000003419655,0.00014957454,0.000096740245,0.00006722286,0.00023633696,0.000088926616,0.000012389349,0.00010711491,0.000013310093],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046714046,0.0047376473,0.016430385,0.006361667,0.0002787069,0.00007778244,0.17874876,0.0000014587682,0.58316225,0.19633822,0.000854443,0.0083372565],"study_design_scores_gemma":[0.003333962,0.0009365724,0.00076949556,0.0001541818,0.00016380513,0.0022932484,0.017750766,0.000025349644,0.9732367,0.00006322134,0.0011281,0.00014460203],"about_ca_topic_score_codex":0.0000024835454,"about_ca_topic_score_gemma":6.203575e-7,"teacher_disagreement_score":0.39007443,"about_ca_system_score_codex":0.00006918474,"about_ca_system_score_gemma":0.00006812477,"threshold_uncertainty_score":0.60994726},"labels":[],"label_agreement":null},{"id":"W2110901075","doi":"10.1186/2162-3619-3-26","title":"Activity of dalotuzumab, a selective anti-IGF1R antibody, in combination with erlotinib in unselected patients with Non-small-cell lung cancer: a phase I/II randomized trial","year":2014,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Merck","keywords":"Erlotinib; Medicine; Internal medicine; Randomized controlled trial; Oncology; Lung cancer; Antibody; Erlotinib Hydrochloride; Cancer; Immunology; Epidermal growth factor receptor","score_opus":0.007392533454674619,"score_gpt":0.30671340821407567,"score_spread":0.29932087475940106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110901075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954258,0.00043108905,0.00015279293,0.00008641209,0.00012187166,0.0031587218,0.000005349908,0.000023775388,0.00059416454],"genre_scores_gemma":[0.9991181,0.00003185109,0.0002447726,0.000094371324,0.000019726951,0.00036728155,0.00008404018,0.00002511096,0.000014752756],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980481,0.00046083445,0.00052308076,0.0004405149,0.00015385958,0.00037359647],"domain_scores_gemma":[0.9989173,0.00036641388,0.0003500255,0.00014415862,0.000118062206,0.00010407181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032618933,0.0002832779,0.0017031855,0.00036750856,0.00008327306,0.000003891965,0.000072610885,0.0003069119,0.000016795086],"category_scores_gemma":[0.000060512175,0.00021143362,0.000060092527,0.00042817616,0.00039222834,0.000120753524,0.000045728848,0.00037314053,5.1292113e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72603816,0.012055091,0.23883657,0.00011569609,0.00014384638,0.00003998445,0.0039049205,0.0000016945355,0.018135078,0.0003314697,0.000024665473,0.00037280176],"study_design_scores_gemma":[0.7981477,0.021184951,0.029160833,0.00012251905,0.00012179975,0.00003549907,0.00020057126,0.001019123,0.14977409,0.000018065277,0.000012112187,0.00020275917],"about_ca_topic_score_codex":0.0006456606,"about_ca_topic_score_gemma":0.00026043935,"teacher_disagreement_score":0.20967573,"about_ca_system_score_codex":0.00020816525,"about_ca_system_score_gemma":0.00034003519,"threshold_uncertainty_score":0.8622013},"labels":[],"label_agreement":null},{"id":"W2150942773","doi":"10.1186/2162-3619-2-26","title":"ABC transporter activity linked to radiation resistance and molecular subtype in pediatric medulloblastoma","year":2013,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; National Institutes of Health; Children's Hospital Foundation; Royal Children's Hospital Foundation; Terry Fox Research Institute; University of Toronto; Pediatric Brain Tumor Foundation","keywords":"Medulloblastoma; Cancer research; Biology; Abcg2; ATP-binding cassette transporter; Apoptosis; In vivo; Cancer stem cell; Stem cell; Glioma; Transporter; Immunology; Cell biology; Genetics; Gene","score_opus":0.007394195033527149,"score_gpt":0.2774493438181646,"score_spread":0.27005514878463743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150942773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99055624,0.004483657,0.0002367508,0.0025247491,0.00015630588,0.00061761995,0.0000016461347,0.00003225902,0.0013907668],"genre_scores_gemma":[0.9970995,0.00017972071,0.0014945526,0.00078409136,0.00003708498,0.00014834711,0.000008177636,0.000015580319,0.00023291646],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990024,0.000052579264,0.00023449115,0.00034600837,0.00008825719,0.0002762791],"domain_scores_gemma":[0.99957454,0.000041866086,0.00005481192,0.000120146615,0.000021128439,0.00018752394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009648827,0.00015843828,0.00043535282,0.0001578475,0.00005515627,0.000005210913,0.000042682215,0.00025922188,0.00012875769],"category_scores_gemma":[0.000007323629,0.00014375137,0.000035514186,0.00014139946,0.00010253078,0.000079369274,0.000013800658,0.00017459337,0.000023898681],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00545645,0.0023919237,0.34780577,0.00069579325,0.00012233577,0.0026539138,0.009379138,0.0000019957627,0.5984385,0.021375848,0.0013852924,0.010293051],"study_design_scores_gemma":[0.005842206,0.0014181235,0.74860454,0.00006200461,0.00008539089,0.0003278388,0.0008470001,0.000034570043,0.23810837,0.0007174052,0.0035527076,0.00039987557],"about_ca_topic_score_codex":0.000032238593,"about_ca_topic_score_gemma":0.00021916107,"teacher_disagreement_score":0.40079874,"about_ca_system_score_codex":0.00007071315,"about_ca_system_score_gemma":0.000061418534,"threshold_uncertainty_score":0.5862011},"labels":[],"label_agreement":null},{"id":"W2287099773","doi":"10.1186/s40164-016-0035-4","title":"Nucleotide excision repair deficiency in melanoma in response to UVA","year":2015,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Health and Medical Research Council; Medical Research Council; Multiple Sclerosis Australia; Cancer Institute NSW; Canadian Institutes of Health Research; Cure Cancer Australia Foundation; Cancer Australia","keywords":"Nucleotide excision repair; Melanoma; Cancer research; Genetics; Medicine; Biology; DNA repair; DNA","score_opus":0.018024735610118747,"score_gpt":0.31898564663437073,"score_spread":0.300960911024252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2287099773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938572,0.002811639,0.00007072536,0.0003551519,0.0002517683,0.0002900692,0.0000017540673,0.000026138814,0.002335521],"genre_scores_gemma":[0.99543023,0.000011972144,0.0035332274,0.0006655835,0.000024952664,0.00008552723,0.000007951639,0.00001663904,0.00022394223],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998378,0.00039361557,0.0003142234,0.00049519486,0.00008025392,0.00033870974],"domain_scores_gemma":[0.99945116,0.00005142084,0.000049098817,0.000259436,0.000021304824,0.00016756539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007133286,0.00015772358,0.0002925272,0.00017034702,0.000032522745,0.000004465029,0.00014264282,0.0003188041,0.000021694743],"category_scores_gemma":[0.00019841728,0.00016052724,0.000042240576,0.0001350284,0.0001077505,0.0000064986866,0.00028933064,0.000111543544,0.000044705434],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006455966,0.0007287917,0.023475753,0.0000086279115,0.000008898843,0.00063138467,0.0020998507,0.000016607712,0.9596672,0.0040683444,0.0022389013,0.0005996799],"study_design_scores_gemma":[0.0039135073,0.00649906,0.008121676,0.00002654611,0.000004158577,0.0010453134,0.0048967274,0.00008495567,0.94947416,0.00069249124,0.024864828,0.0003765995],"about_ca_topic_score_codex":0.000042251642,"about_ca_topic_score_gemma":0.00030501824,"teacher_disagreement_score":0.022625927,"about_ca_system_score_codex":0.00012714091,"about_ca_system_score_gemma":0.00013710419,"threshold_uncertainty_score":0.65461105},"labels":[],"label_agreement":null},{"id":"W2300107978","doi":"10.1186/s40164-016-0037-2","title":"Rare MLL-ELL fusion transcripts in childhood acute myeloid leukemia—association with young age and myeloid sarcomas?","year":2015,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Fusion transcript; Sanger sequencing; Exon; Breakpoint; Fusion gene; Myeloid leukemia; Chromosomal translocation; Myeloid sarcoma; Karyotype; Myeloid; Biology; Cancer research; Cytogenetics; Leukemia; Molecular biology; Medicine; Pathology; Gene; Genetics; DNA sequencing; Chromosome","score_opus":0.018831109176002888,"score_gpt":0.3061671611899829,"score_spread":0.28733605201398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2300107978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98383236,0.0063889306,0.000022382681,0.002042361,0.00020154651,0.00079984555,0.000008915166,0.000071318624,0.0066323276],"genre_scores_gemma":[0.99611104,0.0004981967,0.0012354851,0.00094539794,0.0000939726,0.0001232547,0.00008554046,0.000040338164,0.0008667555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99776876,0.00027870573,0.0004130176,0.0005859304,0.00030953044,0.0006440735],"domain_scores_gemma":[0.9990232,0.00014567934,0.0001384153,0.00022444969,0.00007237599,0.0003958783],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044796063,0.0003117771,0.00086551736,0.00026674222,0.00014094172,0.00002040839,0.000119346114,0.00062355364,0.0000620708],"category_scores_gemma":[0.000060260514,0.00026102012,0.000049691047,0.00024579422,0.00036736653,0.00019570276,0.00014660036,0.0007305139,0.000028693763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011777599,0.0024894108,0.7085471,0.00024106789,0.0007520937,0.027482841,0.05667141,0.0000032288235,0.16906059,0.004460074,0.010725101,0.007789487],"study_design_scores_gemma":[0.09182475,0.019050343,0.42784664,0.00048244395,0.0005269191,0.050299406,0.03275112,0.0005580724,0.35261416,0.0008524201,0.02151341,0.0016803078],"about_ca_topic_score_codex":0.0002672453,"about_ca_topic_score_gemma":0.0004369433,"teacher_disagreement_score":0.28070045,"about_ca_system_score_codex":0.0021083257,"about_ca_system_score_gemma":0.0006503202,"threshold_uncertainty_score":0.9999842},"labels":[],"label_agreement":null},{"id":"W2399733579","doi":"10.1186/s40164-016-0043-4","title":"Patient perspectives of a diagnosis of myeloproliferative neoplasm in a case control study","year":2015,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Queen's University Belfast; National Institute for Health and Care Research","keywords":"Medicine; Myeloproliferative neoplasm; Polycythemia vera; Essential thrombocythemia; Etiology; Internal medicine; Logistic regression; Myelofibrosis; Disease; Denial; Hematology; Medical record; Bone marrow","score_opus":0.026269811310591206,"score_gpt":0.3451570595030722,"score_spread":0.318887248192481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399733579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891557,0.0075345077,0.0000046670134,0.00046794888,0.000085995656,0.0016051421,0.00002294947,0.000010786091,0.0011122796],"genre_scores_gemma":[0.9983741,0.00005152313,0.0004945516,0.0001266611,0.000015466196,0.00091297337,0.000002425029,0.00001177049,0.000010532129],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99839383,0.00035684012,0.00054972095,0.00034980028,0.00013763072,0.00021218056],"domain_scores_gemma":[0.998893,0.00042537978,0.00020581111,0.00015906375,0.00015108303,0.00016561642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019348042,0.00020645723,0.0010693033,0.00019392215,0.000039628674,0.0000022953461,0.000032758115,0.00015142211,0.00008822461],"category_scores_gemma":[0.00013517796,0.00016331991,0.00006545968,0.00013925633,0.00034172364,0.000052550367,0.000061037565,0.0001464889,0.0000034087327],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022407442,0.013111448,0.8705785,0.000030697378,0.00034654402,0.00660735,0.10146648,0.000003373193,0.00019767704,0.003907066,0.000088747416,0.0014213504],"study_design_scores_gemma":[0.04229138,0.057292875,0.12310731,0.0001470764,0.00032256372,0.017537491,0.5676748,0.0001360213,0.19078289,0.00019686163,0.00017094852,0.00033973908],"about_ca_topic_score_codex":0.00023720959,"about_ca_topic_score_gemma":0.00039311705,"teacher_disagreement_score":0.7474712,"about_ca_system_score_codex":0.00020142399,"about_ca_system_score_gemma":0.00020836465,"threshold_uncertainty_score":0.66599923},"labels":[],"label_agreement":null},{"id":"W2672210777","doi":"10.1186/s40164-017-0078-1","title":"Low-dose methotrexate in sickle-cell disease: a pilot study with rationale borrowed from rheumatoid arthritis","year":2017,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Instituto UNIEMP; Universidade Estadual de Campinas","keywords":"Medicine; Methotrexate; Internal medicine; Rheumatoid arthritis; Adverse effect; Gastroenterology; Inflammatory bowel disease; Disease","score_opus":0.018065707391931377,"score_gpt":0.3064347565468245,"score_spread":0.28836904915489314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2672210777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812478,0.013299398,0.000013787811,0.0013808929,0.00019013185,0.00094051904,0.000009490085,0.00003544687,0.0028825558],"genre_scores_gemma":[0.9979272,0.00069100765,0.0004938373,0.00038155488,0.00002368322,0.00020337604,0.000037926995,0.000022705863,0.00021873297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862003,0.00017311632,0.00033139598,0.00045254076,0.0001235362,0.0002993706],"domain_scores_gemma":[0.99907875,0.00012499485,0.00016641327,0.0003771583,0.000029318808,0.00022333788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014738482,0.00021643873,0.00062677223,0.00008431224,0.0003160398,0.000021621923,0.00011686899,0.0001295006,0.00031011368],"category_scores_gemma":[0.000051891966,0.00017473874,0.00003438952,0.000046565216,0.00046422126,0.00011222845,0.000114319904,0.00028489772,0.000044750283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03454029,0.04245476,0.84602,0.00013256019,0.000470955,0.017033393,0.01300594,0.000010120561,0.034305803,0.005026383,0.0015303418,0.0054694675],"study_design_scores_gemma":[0.14899719,0.049491916,0.639987,0.001143103,0.00022951367,0.0022230158,0.04872156,0.0006933172,0.09967103,0.0014034486,0.0058276122,0.0016113215],"about_ca_topic_score_codex":0.00042029188,"about_ca_topic_score_gemma":0.000609464,"teacher_disagreement_score":0.20603302,"about_ca_system_score_codex":0.00007085202,"about_ca_system_score_gemma":0.00019719897,"threshold_uncertainty_score":0.71256393},"labels":[],"label_agreement":null},{"id":"W2735791343","doi":"10.1186/s40164-017-0080-7","title":"Apixaban for treatment of confirmed heparin-induced thrombocytopenia: a case report and review of literature","year":2017,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Argatroban; Medicine; Apixaban; Heparin-induced thrombocytopenia; Heparin; Thrombosis; Platelet factor 4; Platelet activation; Anticoagulant; Direct thrombin inhibitor; Discovery and development of direct thrombin inhibitors; Surgery; Internal medicine; Anesthesia; Platelet; Rivaroxaban; Warfarin; Dabigatran; Thrombin; Atrial fibrillation","score_opus":0.07314740565924846,"score_gpt":0.4247223183356783,"score_spread":0.3515749126764298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735791343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9564758,0.036900397,0.0000043209616,0.0013295944,0.0002454441,0.001499186,0.000023892962,0.000015899135,0.0035054993],"genre_scores_gemma":[0.9931473,0.004939616,0.0012083853,0.00023342903,0.000051022405,0.0002228588,0.000043022927,0.00002099512,0.00013335494],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99842334,0.00008235137,0.0006760172,0.0004654979,0.00007988026,0.000272935],"domain_scores_gemma":[0.9982844,0.00017999258,0.00057791267,0.00063513726,0.00013469283,0.00018783573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022706813,0.00026818656,0.0020234003,0.00007787594,0.00025882354,0.00001123787,0.000089918736,0.00035947122,0.000073364965],"category_scores_gemma":[0.00015424982,0.00021125104,0.00016330277,0.000044549048,0.0005627515,0.00010279371,0.00011111727,0.00009146023,0.00000150229],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00485328,0.009846148,0.06690074,0.021672554,0.0036556167,0.13400789,0.014218623,2.0380309e-8,0.6532532,0.06338172,0.0015057904,0.026704434],"study_design_scores_gemma":[0.007968329,0.008232486,0.0066880165,0.00218344,0.00056210154,0.28369534,0.0006429966,0.0000076924425,0.68546945,0.00019516637,0.0041042096,0.00025079984],"about_ca_topic_score_codex":0.00019862676,"about_ca_topic_score_gemma":0.00007292696,"teacher_disagreement_score":0.14968745,"about_ca_system_score_codex":0.00009915215,"about_ca_system_score_gemma":0.00021335181,"threshold_uncertainty_score":0.86145675},"labels":[],"label_agreement":null},{"id":"W2805371265","doi":"10.1186/s40164-018-0098-5","title":"Aplastic anemia secondary to nivolumab and ipilimumab in a patient with metastatic melanoma: a case report","year":2018,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Ipilimumab; Nivolumab; Internal medicine; Aplastic anemia; Neutropenia; Oncology; Cancer; Bone marrow; Immunotherapy; Chemotherapy","score_opus":0.012702777517378966,"score_gpt":0.3125096891512824,"score_spread":0.29980691163390344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805371265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932987,0.003712681,0.000027243295,0.00048724774,0.00016100916,0.0004877852,0.0000041275775,0.000020689322,0.0018004968],"genre_scores_gemma":[0.9966573,0.000011719178,0.0019525946,0.0011288583,0.000026666206,0.00011124038,0.000007445966,0.000013894794,0.00009024079],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9989159,0.00007027903,0.000325126,0.00036983882,0.00006565718,0.00025320082],"domain_scores_gemma":[0.999503,0.000093941875,0.00008403837,0.00015421667,0.000027210486,0.00013754673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011923627,0.0001595998,0.000452193,0.00014003426,0.00009631208,0.0000058434266,0.000025358177,0.00010692024,0.0002396282],"category_scores_gemma":[0.000016956776,0.00012556885,0.000022966615,0.00012340763,0.0004838715,0.000045672914,0.000056249268,0.00013838346,0.000007910462],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04694923,0.0020082716,0.0154658025,0.00028505616,0.00043256336,0.8578515,0.024834523,2.5001177e-7,0.024618812,0.00084056327,0.003234965,0.023478467],"study_design_scores_gemma":[0.009040708,0.0151097495,0.0017718195,0.00007672264,0.00005462624,0.9135223,0.0068061464,0.00002202121,0.049520746,0.000026599484,0.0038638625,0.00018468205],"about_ca_topic_score_codex":0.00028196603,"about_ca_topic_score_gemma":0.001199071,"teacher_disagreement_score":0.055670824,"about_ca_system_score_codex":0.00015259218,"about_ca_system_score_gemma":0.00017859908,"threshold_uncertainty_score":0.5120549},"labels":[],"label_agreement":null},{"id":"W2890474078","doi":"10.1186/s40164-018-0114-9","title":"Clinical confirmation to demonstrate similarity for a biosimilar pegfilgrastim: a 3-way randomized equivalence study for a proposed biosimilar pegfilgrastim versus US-licensed and EU-approved reference products in breast cancer patients receiving myelosuppressive chemotherapy","year":2018,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hydro One (Canada); Apotex (Canada)","funders":"","keywords":"Biosimilar; Pegfilgrastim; Medicine; Breast cancer; Equivalence (formal languages); Oncology; Internal medicine; Pharmacology; Medical physics; Filgrastim; Cancer; Granulocyte colony-stimulating factor; Chemotherapy; Mathematics","score_opus":0.057752972183594625,"score_gpt":0.41614632596557355,"score_spread":0.3583933537819789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890474078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851692,0.00024462302,0.00021024593,0.0043088584,0.0007461141,0.008999316,0.000101690224,0.000053367952,0.00016660386],"genre_scores_gemma":[0.99252665,0.0001078016,0.0028344009,0.0016183683,0.0001715154,0.0026471734,0.000038824463,0.00003267044,0.000022566943],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997255,0.00042400332,0.00080774026,0.00088900846,0.00013477386,0.0004894265],"domain_scores_gemma":[0.9980149,0.0007740095,0.0003255666,0.00023280928,0.00042711417,0.00022555642],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00067646167,0.00034483976,0.0013037657,0.00017343901,0.00030407877,0.00002487609,0.00011362448,0.0003272858,0.000054965127],"category_scores_gemma":[0.00035553158,0.00029197094,0.00009250281,0.00022194469,0.0008254215,0.00012947914,0.00009072452,0.00026056578,0.0000024431265],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7016794,0.009374785,0.20715053,0.0005922357,0.00089188723,0.000036422825,0.010405272,0.0000013874784,0.058561757,0.00064243714,0.0029825426,0.0076813423],"study_design_scores_gemma":[0.64352834,0.03193617,0.12453254,0.0005697634,0.0008480268,0.00034205144,0.0041682418,0.001639257,0.18906073,0.0001216113,0.0022131596,0.0010400813],"about_ca_topic_score_codex":0.000081331775,"about_ca_topic_score_gemma":0.00040854805,"teacher_disagreement_score":0.13049898,"about_ca_system_score_codex":0.00017295718,"about_ca_system_score_gemma":0.00031407477,"threshold_uncertainty_score":0.99995327},"labels":[],"label_agreement":null},{"id":"W3036033661","doi":"10.1186/s40164-020-00170-6","title":"Leukemia incidence trends at the global, regional, and national level between 1990 and 2017","year":2020,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":348,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Medical Association","funders":"Department of Education of Guizhou Province; Guizhou Science and Technology Department; National Natural Science Foundation of China","keywords":"Medicine; Leukemia; Incidence (geometry); Myeloid leukemia; Chronic lymphocytic leukemia; Internal medicine; Demography","score_opus":0.12036463846384143,"score_gpt":0.4121852002020398,"score_spread":0.29182056173819837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036033661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9437476,0.011331539,0.000016465136,0.039205506,0.000041390456,0.00018726477,0.00003318991,0.00002746913,0.0054095807],"genre_scores_gemma":[0.9923555,0.00035178527,0.00053970783,0.0060640275,0.00015545834,0.000037465394,0.000047289777,0.000009425511,0.00043930043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987877,0.00012011087,0.00022053592,0.00040356774,0.00020228239,0.0002658294],"domain_scores_gemma":[0.99915826,0.00034714205,0.00007524143,0.00011038372,0.000037734335,0.00027123888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018999961,0.00016065757,0.0004064975,0.000045260524,0.0002950294,0.000010964113,0.00010241923,0.00025219898,0.00015051774],"category_scores_gemma":[0.00008863221,0.000117449956,0.00003205544,0.00012443932,0.0012699161,0.00007447231,0.00043917852,0.00028089332,0.000029091272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003176021,0.00020115198,0.49266684,0.00017141728,0.0005128492,0.0015175188,0.0060003195,8.3858487e-7,0.012161741,0.058064945,0.4138475,0.011678852],"study_design_scores_gemma":[0.016750887,0.005506565,0.5875785,0.000092994545,0.00022126298,0.046229158,0.0055781845,0.00094928854,0.028806975,0.0022404385,0.3052614,0.00078433054],"about_ca_topic_score_codex":0.00008978256,"about_ca_topic_score_gemma":0.000050727074,"teacher_disagreement_score":0.10858608,"about_ca_system_score_codex":0.00065335294,"about_ca_system_score_gemma":0.00034483275,"threshold_uncertainty_score":0.478947},"labels":[],"label_agreement":null},{"id":"W3119693976","doi":"10.1186/s40164-020-00197-9","title":"AP-1 family transcription factors: a diverse family of proteins that regulate varied cellular activities in classical hodgkin lymphoma and ALK+ ALCL","year":2021,"lang":"en","type":"review","venue":"Experimental Hematology and Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Toronto; University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada; Institute of Infection and Immunity; Canadian Institutes of Health Research","keywords":"Transcription factor; Lymphoma; Cancer research; Hodgkin lymphoma; Transcription (linguistics); Cell biology; Biology; Chemistry; Genetics; Gene; Immunology","score_opus":0.0726494717260614,"score_gpt":0.3470231436944375,"score_spread":0.2743736719683761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119693976","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2610515,0.73698896,0.00000722158,0.000044768363,0.00020944202,0.00113419,0.000038568338,0.000022535829,0.00050278736],"genre_scores_gemma":[0.33891582,0.659906,0.00029792855,0.00007726842,0.000034989967,0.00043612288,0.00021201833,0.000035680685,0.00008412584],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997454,0.0005082987,0.000690756,0.0007497894,0.00018846759,0.00040868428],"domain_scores_gemma":[0.9988379,0.00033059745,0.00033308016,0.00029686236,0.000021888674,0.00017965524],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001411385,0.00058519153,0.0035520063,0.00028693222,0.00009531128,0.000014585735,0.00009005493,0.0010841145,0.000049933005],"category_scores_gemma":[0.00001430017,0.00045687833,0.00036491803,0.00015231087,0.0006567727,0.000096236385,0.00014708078,0.00022808094,0.0000035837],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016569534,0.017230975,0.008626,0.017803527,0.0032234893,0.010056109,0.010790323,1.3291425e-7,0.0117366575,0.022960825,0.0009127763,0.89500225],"study_design_scores_gemma":[0.029905817,0.009480222,0.010156475,0.02300435,0.0049615777,0.0065985695,0.02454093,0.000024199353,0.07951256,0.00018317935,0.80964273,0.001989378],"about_ca_topic_score_codex":0.0001877213,"about_ca_topic_score_gemma":0.000040214196,"teacher_disagreement_score":0.8930129,"about_ca_system_score_codex":0.000536926,"about_ca_system_score_gemma":0.00045717676,"threshold_uncertainty_score":0.9997883},"labels":[],"label_agreement":null},{"id":"W4220932718","doi":"10.1186/s40164-022-00268-z","title":"Matching-adjusted indirect treatment comparison of chimeric antigen receptor T-cell therapies for third-line or later treatment of relapsed or refractory large B-cell lymphoma: lisocabtagene maraleucel versus tisagenlecleucel","year":2022,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; EVERSANA (Canada)","funders":"Bristol-Myers Squibb; American Society of Hematology","keywords":"Medicine; Oncology; Hazard ratio; Internal medicine; Confidence interval; Cytokine release syndrome; Odds ratio; Chimeric antigen receptor; Immunology; Immunotherapy; Cancer","score_opus":0.07916506812500414,"score_gpt":0.3910096793426737,"score_spread":0.3118446112176696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220932718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9751572,0.02080475,0.000014481248,0.0001983401,0.00060701725,0.0018474646,0.00016204912,0.000055763274,0.0011529126],"genre_scores_gemma":[0.984604,0.0018174122,0.0018441164,0.000094230476,0.000077880206,0.00077092805,0.00030246886,0.00007013754,0.010418821],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99737835,0.00046685102,0.0007682974,0.00056647864,0.00025480965,0.0005652153],"domain_scores_gemma":[0.99815196,0.0007842827,0.00044158584,0.00040426574,0.00005800895,0.00015992516],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023730734,0.0004053162,0.0016605085,0.00027343072,0.00030761893,0.000005485936,0.00016256783,0.00029794042,0.003685311],"category_scores_gemma":[0.000010543467,0.00029273806,0.00025915971,0.00024561232,0.0003128765,0.000048622915,0.0001324875,0.00014800692,0.0000115055545],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14697213,0.048698273,0.0063490756,0.00028331,0.0014223712,0.0002659425,0.03714463,0.000005012665,0.74205947,0.00010106616,0.0017298503,0.014968886],"study_design_scores_gemma":[0.05965948,0.07529414,0.00046077938,0.000015655087,0.00019029001,0.00018197087,0.016338265,0.00011231668,0.7907352,0.000008381434,0.056762137,0.00024141048],"about_ca_topic_score_codex":0.00015152921,"about_ca_topic_score_gemma":0.00012814146,"teacher_disagreement_score":0.08731266,"about_ca_system_score_codex":0.0009284829,"about_ca_system_score_gemma":0.00048587745,"threshold_uncertainty_score":0.9999525},"labels":[],"label_agreement":null},{"id":"W4220995900","doi":"10.1186/s40164-022-00272-3","title":"Trends in platelet count among cancer patients","year":2022,"lang":"en","type":"letter","venue":"Experimental Hematology and Oncology","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Platelet; Cancer; Internal medicine; Lung cancer; Stomach cancer; Hematology; Incidence (geometry); Gastroenterology; Oncology","score_opus":0.016487234769639578,"score_gpt":0.32386314138243305,"score_spread":0.30737590661279346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220995900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90444666,0.009699096,1.0551382e-7,0.07532404,0.0018713945,0.0007557156,0.00012731957,0.00008245059,0.007693239],"genre_scores_gemma":[0.6058953,0.0001922118,0.0001007269,0.38658628,0.0006735843,0.0027112167,0.0021353676,0.000118535216,0.0015867774],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976206,0.00027355916,0.0005596098,0.00069329963,0.0002728585,0.00058007083],"domain_scores_gemma":[0.99920774,0.00012733949,0.0002568168,0.00026054017,0.00003247026,0.000115102725],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012537994,0.00040708584,0.0010671685,0.0006025863,0.0001371479,0.000007743829,0.00016096534,0.0013330043,0.0083786165],"category_scores_gemma":[0.000014343226,0.00040445602,0.00014708143,0.00019813805,0.00057252776,0.000058889436,0.0002807117,0.0015899237,0.000015048151],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008426737,0.0005700457,0.29629752,0.00014936613,0.00019872189,0.0070373793,0.0005386783,6.932506e-8,0.00001966938,0.000039737904,0.69255865,0.0017474953],"study_design_scores_gemma":[0.0059755873,0.0015277213,0.048644856,0.00012546394,0.00014483454,0.00059093523,0.00027528917,0.000021518355,0.0031915328,0.000022143511,0.9389471,0.00053301884],"about_ca_topic_score_codex":0.0001264096,"about_ca_topic_score_gemma":0.000052095038,"teacher_disagreement_score":0.31126225,"about_ca_system_score_codex":0.0011257542,"about_ca_system_score_gemma":0.0001819842,"threshold_uncertainty_score":0.99996346},"labels":[],"label_agreement":null},{"id":"W4295943093","doi":"10.1186/s40164-022-00310-0","title":"Multi-omic profiling of the leukemic microenvironment shows bone marrow interstitial fluid is distinct from peripheral blood plasma","year":2022,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; BC Children's Hospital; University of British Columbia","funders":"Michael Cuccione Foundation; Canadian Institutes of Health Research; Canada Research Chairs; Michael Smith Health Research BC; BC Children's Hospital; Children's Hospital Foundation","keywords":"Bone marrow; Medicine; Interstitial fluid; Haematopoiesis; Extracellular fluid; Pathology; Leukemia; Immunology; Stem cell; Cell biology; Biology; Extracellular","score_opus":0.016777277780627983,"score_gpt":0.29104835976169247,"score_spread":0.2742710819810645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295943093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944943,0.0028580755,0.000056007724,0.0010264931,0.00048407516,0.00063303165,0.00011989382,0.000022774813,0.00030535404],"genre_scores_gemma":[0.9953673,0.000022230497,0.002673037,0.0010177456,0.000073999734,0.00021946068,0.00005667057,0.000030094041,0.0005394769],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99815583,0.00026719357,0.0004531233,0.00048061728,0.00024935565,0.00039390274],"domain_scores_gemma":[0.999192,0.00018499771,0.00015906054,0.00032589174,0.000014050847,0.00012398059],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014731883,0.0002229569,0.0006023856,0.0000673131,0.00029855306,0.0000048428333,0.00023736026,0.00017281239,0.0022975246],"category_scores_gemma":[0.000032780332,0.00017789907,0.00013320036,0.000076100725,0.0008747832,0.000033874843,0.00095163664,0.00047988925,0.000012639511],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025052077,0.0012825064,0.025519349,0.000047278292,0.00024229614,0.0004987017,0.0033862956,0.0000051196257,0.96411324,0.00020709253,0.0019447167,0.00024818798],"study_design_scores_gemma":[0.012537894,0.0020082705,0.0022018254,0.000035440167,0.00015190346,0.0058898195,0.0054418123,0.0045463936,0.96492064,0.000023062643,0.002048802,0.00019410765],"about_ca_topic_score_codex":0.00019366012,"about_ca_topic_score_gemma":0.000026623004,"teacher_disagreement_score":0.023317523,"about_ca_system_score_codex":0.001320968,"about_ca_system_score_gemma":0.00040660065,"threshold_uncertainty_score":0.9986145},"labels":[],"label_agreement":null},{"id":"W4308522406","doi":"10.1186/s40164-022-00339-1","title":"Pan-cancer landscape of aberrant DNA Methylation across childhood Cancers: Molecular Characteristics and Clinical relevance","year":2022,"lang":"en","type":"letter","venue":"Experimental Hematology and Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Genome British Columbia; University of British Columbia","funders":"Southern Methodist University","keywords":"dNaM; DNA methylation; Cancer; Epigenetics; Medicine; Carcinogenesis; Methylation; CpG site; Oncology; Cancer research; Internal medicine; Bioinformatics; Biology; Genetics; Gene; Gene expression","score_opus":0.01870720497526948,"score_gpt":0.35887694917859453,"score_spread":0.340169744203325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308522406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9226729,0.066564,0.0000930751,0.008790179,0.00097244343,0.00039260075,0.00022278656,0.000011568692,0.00028043758],"genre_scores_gemma":[0.9564047,0.014327028,0.00051083136,0.0262053,0.0009035209,0.00019813412,0.0011891307,0.00007055461,0.0001908429],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99757665,0.00043627806,0.0007192846,0.0007421351,0.00015403797,0.00037163458],"domain_scores_gemma":[0.99878424,0.00015660806,0.0005958932,0.00032872643,0.00006343749,0.00007111652],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035436344,0.00032934168,0.00081236137,0.00005656813,0.00015199337,0.000011983016,0.00017623244,0.0012641376,0.0001181022],"category_scores_gemma":[0.00008415064,0.00033778552,0.0001395794,0.0000647889,0.00045389502,0.000005886363,0.00035040968,0.0007213687,0.0000013884624],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033130238,0.0020525388,0.07708767,0.0011856195,0.0036643385,0.00094397156,0.004814421,0.000026834146,0.667588,0.0009579166,0.12157845,0.11678724],"study_design_scores_gemma":[0.0026180441,0.0035236902,0.008445002,0.000058289115,0.00018399321,0.00013803721,0.00043942718,0.000042412394,0.38979337,0.00020113865,0.59383047,0.00072613615],"about_ca_topic_score_codex":0.000042274565,"about_ca_topic_score_gemma":0.000030974446,"teacher_disagreement_score":0.472252,"about_ca_system_score_codex":0.00005852074,"about_ca_system_score_gemma":0.00020382622,"threshold_uncertainty_score":0.99990743},"labels":[],"label_agreement":null},{"id":"W4318316239","doi":"10.1186/s40164-023-00375-5","title":"Depletion of polyfunctional CD26highCD8+ T cells repertoire in chronic lymphocytic leukemia","year":2023,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of Alberta; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Cytotoxic T cell; CD8; Immunology; Perforin; Chronic lymphocytic leukemia; TIGIT; Interleukin 21; T cell; Granzyme B; Cytokine; Biology; Cancer research; Medicine; Immune system; Leukemia","score_opus":0.013369603422608392,"score_gpt":0.27885258195266605,"score_spread":0.26548297853005765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318316239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847582,0.007885971,0.000027315298,0.00012420908,0.0040079653,0.00020010362,0.0000028551683,0.00011073704,0.0028826648],"genre_scores_gemma":[0.9948818,0.00025320286,0.000021645777,0.00017696679,0.000030979485,0.000066052744,0.00011815319,0.000014131387,0.004437041],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864966,0.00021887942,0.00044801223,0.00032542364,0.000031178566,0.00032682667],"domain_scores_gemma":[0.9994369,0.00021151548,0.00014799413,0.00015514689,0.000027246553,0.000021188365],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00018725535,0.00016387446,0.00040510285,0.00031558148,0.00013220983,0.0000031152797,0.000088846085,0.00045650985,0.0014891694],"category_scores_gemma":[0.000023279377,0.00015949311,0.0000723441,0.00022509812,0.00036449885,0.000099128316,0.00009418522,0.00024260215,0.00078671146],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006894743,0.0000775069,0.0010526441,0.000031178104,0.000059537506,0.000033384254,0.0006003794,0.00008538444,0.97872716,0.0057815867,0.011929664,0.000932099],"study_design_scores_gemma":[0.0031679946,0.0009951092,0.002462077,0.000037656864,0.000011176429,0.00075957,0.0015668999,0.0003572272,0.94365853,0.00008000948,0.046738535,0.0001652089],"about_ca_topic_score_codex":0.00029823367,"about_ca_topic_score_gemma":0.00006383758,"teacher_disagreement_score":0.035068627,"about_ca_system_score_codex":0.002035406,"about_ca_system_score_gemma":0.00050704397,"threshold_uncertainty_score":0.9999913},"labels":[],"label_agreement":null},{"id":"W4390912419","doi":"10.1186/s40164-024-00473-y","title":"Outcomes of allogeneic hematopoietic stem cell transplantation in R/R DLBCL patients with failure of CAR-T therapy","year":2024,"lang":"en","type":"letter","venue":"Experimental Hematology and Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"York University","keywords":"Medicine; Internal medicine; Hematopoietic stem cell transplantation; Hematology; Lymphoma; Transplantation; Refractory (planetary science); Surgery; Oncology","score_opus":0.018795935414203605,"score_gpt":0.3165809880801099,"score_spread":0.2977850526659063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390912419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97137296,0.0072733904,0.0000029175194,0.018973816,0.00019980139,0.0011548282,0.000050920436,0.00002131109,0.0009500381],"genre_scores_gemma":[0.98166513,0.00042082265,0.000179299,0.015939422,0.000067789326,0.00017109618,0.00029997004,0.00007948964,0.0011769967],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979555,0.00022926668,0.0006303755,0.0004873167,0.0003277065,0.00036983576],"domain_scores_gemma":[0.9990784,0.0002834936,0.00021814638,0.0002892951,0.00006960218,0.000061064624],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012817518,0.00035741847,0.0015014583,0.00039921261,0.00002370081,0.0000038477124,0.0001398322,0.0010464677,0.0006542044],"category_scores_gemma":[0.000001566417,0.0002638269,0.00014618831,0.00015594017,0.0004905744,0.000033957913,0.00004327274,0.00093371916,0.000011866058],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008800928,0.0054127676,0.8408344,0.009169917,0.0018160194,0.0065623485,0.02448986,0.0000013468187,0.0505721,0.0004755715,0.0491846,0.0026801825],"study_design_scores_gemma":[0.032808937,0.013970218,0.030935181,0.0009508365,0.0004482626,0.002022998,0.0034360474,0.0000053893823,0.8489534,0.00012440923,0.0654403,0.00090397365],"about_ca_topic_score_codex":0.00005547698,"about_ca_topic_score_gemma":0.000036715548,"teacher_disagreement_score":0.80989915,"about_ca_system_score_codex":0.00014879223,"about_ca_system_score_gemma":0.00021115728,"threshold_uncertainty_score":0.9999814},"labels":[],"label_agreement":null},{"id":"W4401529334","doi":"10.1186/s40164-024-00550-2","title":"M2-like tumor-associated macrophage-secreted CCL2 facilitates gallbladder cancer stemness and metastasis","year":2024,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Education and Child Care","funders":"","keywords":"Cancer research; Cancer stem cell; Metastasis; Tumor-associated macrophage; CD44; CCR2; Biology; Tumor microenvironment; Chemokine; Epithelial–mesenchymal transition; CCL5; CCL2; Cancer; Chemokine receptor; Stem cell; Immune system; Immunology; Cell; T cell; Cell biology; IL-2 receptor","score_opus":0.01659646511234917,"score_gpt":0.30931182019321296,"score_spread":0.29271535508086377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401529334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6542219,0.34048808,0.000016974245,0.0004300234,0.003156229,0.00031457868,0.00010275896,0.00018454841,0.0010849389],"genre_scores_gemma":[0.99379987,0.0011372843,0.0000972887,0.000742838,0.000030510919,0.0003270749,0.00010142041,0.00004655541,0.003717137],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974263,0.00053532823,0.00050837174,0.00078343006,0.000050694354,0.0006959264],"domain_scores_gemma":[0.99897194,0.0005545355,0.00011936365,0.0002341034,0.00005303064,0.00006705368],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032842942,0.00041644872,0.0008482583,0.00018721726,0.00034731804,0.0000347769,0.00019804308,0.0006331611,0.0037543403],"category_scores_gemma":[0.00003724085,0.00037090562,0.00010688809,0.00019392624,0.001330876,0.00015831036,0.00030730985,0.0006112211,0.00027485215],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014012941,0.0009854926,0.008788295,0.0005916577,0.004151025,0.0015608885,0.014799997,0.0000040512236,0.8907937,0.016997257,0.04095214,0.018974245],"study_design_scores_gemma":[0.0040400135,0.0012006076,0.00152088,0.00019491016,0.00030274797,0.0038390046,0.0065071103,0.00006766338,0.7555123,0.00044678306,0.225534,0.0008339925],"about_ca_topic_score_codex":0.00032560492,"about_ca_topic_score_gemma":0.00012271084,"teacher_disagreement_score":0.33957803,"about_ca_system_score_codex":0.00026663116,"about_ca_system_score_gemma":0.00018319587,"threshold_uncertainty_score":0.9998743},"labels":[],"label_agreement":null},{"id":"W4401955747","doi":"10.1186/s40164-024-00558-8","title":"Polyunsaturated fatty acids promote M2-like TAM deposition via dampening RhoA-YAP1 signaling in the ovarian cancer microenvironment","year":2024,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Science Foundation of Zhejiang Province; Cornell Center for Materials Research; Research and Innovation Foundation; University of Hong Kong; National Natural Science Foundation of China; University of Ottawa; Health and Medical Research Fund; Impact Fund","keywords":"RHOA; Polyunsaturated fatty acid; Tumor microenvironment; Chemistry; YAP1; Cell biology; Cancer research; Cancer; Internal medicine; Signal transduction; Biochemistry; Biology; Medicine; Gene; Fatty acid; Transcription factor","score_opus":0.010716895562758186,"score_gpt":0.28856084481375693,"score_spread":0.27784394925099876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401955747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97400093,0.023113614,0.0012027298,0.00062498834,0.000449035,0.00031496197,0.000010851849,0.000028314375,0.0002545979],"genre_scores_gemma":[0.99736816,0.00016277462,0.0010261697,0.00087492727,0.00015725795,0.00017578744,0.00013147472,0.000025206811,0.00007827254],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984323,0.00028740388,0.00030174237,0.00052397023,0.000089760666,0.0003648673],"domain_scores_gemma":[0.99963236,0.000041667663,0.00006258282,0.0001851543,0.000010690343,0.000067563225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028109679,0.00023090448,0.00025811823,0.00006876637,0.00019230349,0.00003687852,0.00016096752,0.0003757871,0.00006805574],"category_scores_gemma":[0.0000061197366,0.00018419685,0.00007009185,0.00010646346,0.00021845296,0.000010454223,0.00009554217,0.00028445336,0.000015200741],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016417186,0.00015646721,0.00095163303,0.000029070743,0.00006201145,0.00022391973,0.0018881265,0.000018044193,0.9938573,0.00030062444,0.000079182064,0.002269441],"study_design_scores_gemma":[0.00065192184,0.0006393724,0.00032314615,0.00007061992,0.00002970925,0.00109961,0.0009213028,0.00041280276,0.9867431,0.00006992481,0.008808465,0.00023003509],"about_ca_topic_score_codex":0.00009691158,"about_ca_topic_score_gemma":0.000074481606,"teacher_disagreement_score":0.023367222,"about_ca_system_score_codex":0.00008237892,"about_ca_system_score_gemma":0.00008410255,"threshold_uncertainty_score":0.75113297},"labels":[],"label_agreement":null},{"id":"W4408157999","doi":"10.1186/s40164-025-00610-1","title":"Matching-adjusted indirect comparison of efficacy and safety of lisocabtagene maraleucel and mosunetuzumab for the treatment of third-line or later relapsed or refractory follicular lymphoma","year":2025,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Follicular lymphoma; Refractory (planetary science); Medicine; Oncology; Follicular phase; Internal medicine; Lymphoma; Second line; First line; Biology","score_opus":0.051390398366162875,"score_gpt":0.39864506947045025,"score_spread":0.34725467110428737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408157999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9724488,0.025385559,0.00004516437,0.00042353806,0.000113054484,0.0012847566,0.000017246057,0.000012579776,0.00026928552],"genre_scores_gemma":[0.99492127,0.0022982834,0.0008154823,0.00008536074,0.00001890552,0.00010450908,0.000020473539,0.00001536743,0.0017203577],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99870074,0.00016387632,0.0005561208,0.00027386777,0.00009759803,0.00020782487],"domain_scores_gemma":[0.99794316,0.001508969,0.00019545274,0.00023549407,0.00005427351,0.00006267532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020520826,0.00018280777,0.0011397226,0.00013284905,0.000104683786,0.0000027138553,0.00007054265,0.00028110994,0.00017862662],"category_scores_gemma":[0.000034679124,0.00010601016,0.000077012905,0.00012487828,0.0006554743,0.000023456827,0.000072871364,0.000082978164,2.9699692e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22929852,0.011776406,0.040553693,0.0015560932,0.0035676477,0.00017702613,0.028798351,0.000007913149,0.5630775,0.0028107988,0.00074502226,0.11763101],"study_design_scores_gemma":[0.033061285,0.020741874,0.017919594,0.00016236509,0.0003754158,0.00035207992,0.005311446,0.0004244722,0.91102785,0.000067619236,0.010425144,0.00013087844],"about_ca_topic_score_codex":0.00010379922,"about_ca_topic_score_gemma":0.00011245702,"teacher_disagreement_score":0.3479503,"about_ca_system_score_codex":0.00013027152,"about_ca_system_score_gemma":0.0001840478,"threshold_uncertainty_score":0.43229687},"labels":[],"label_agreement":null},{"id":"W4410043874","doi":"10.1186/s40164-025-00630-x","title":"IL-6-mediated tumorigenicity and antioxidant state in squamous cell carcinoma cells are driven by CD109 via stabilization of IL-6 receptor-alpha and activation of STAT3/NRF2 pathway","year":2025,"lang":"en","type":"article","venue":"Experimental Hematology and Oncology","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research; Fonds de recherche du Québec; McGill University Health Centre; McGill University","keywords":"Cancer research; Head and neck squamous-cell carcinoma; Metastasis; Cancer; Malignant transformation; Medicine; STAT3; Signal transduction; Cytokine; Cell; Biology; Head and neck cancer; Immunology; Internal medicine; Cell biology","score_opus":0.00991955200636968,"score_gpt":0.2768775731230813,"score_spread":0.26695802111671163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410043874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99718636,0.0014710991,0.00032651584,0.00013144687,0.00014937419,0.00042173112,0.00011391384,0.000014136513,0.00018544856],"genre_scores_gemma":[0.99938726,0.00011753024,0.00023409206,0.0000974445,0.000007899403,0.000026538617,0.00007063669,0.000010829402,0.00004777393],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99881464,0.00014022987,0.00049475086,0.0002975534,0.000075216354,0.00017758533],"domain_scores_gemma":[0.999196,0.0002709794,0.00027246287,0.00011069197,0.00007992027,0.0000699706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012162981,0.000156332,0.0005628091,0.00020082516,0.00005657343,0.000003478558,0.000035248442,0.00016547192,0.000044805867],"category_scores_gemma":[0.00003976624,0.0001490559,0.000031878495,0.00015854932,0.00028257712,0.00008288094,0.000061156294,0.00017475628,7.6725536e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006480442,0.0015090372,0.0642846,0.00023740558,0.000017315679,0.000013229437,0.0020521109,0.0000021403366,0.93052113,0.00020860598,0.00023966882,0.00026668597],"study_design_scores_gemma":[0.004575752,0.0014107204,0.013337428,0.000075122654,0.000020597618,0.000038171678,0.0025492408,0.00045797686,0.9769467,0.000069118934,0.00041768872,0.0001014933],"about_ca_topic_score_codex":0.00033055453,"about_ca_topic_score_gemma":0.00007879182,"teacher_disagreement_score":0.050947174,"about_ca_system_score_codex":0.00010279158,"about_ca_system_score_gemma":0.00010881594,"threshold_uncertainty_score":0.6078323},"labels":[],"label_agreement":null},{"id":"W4410464105","doi":"10.1186/s40164-025-00662-3","title":"Next-generation immunotherapeutic approaches for blood cancers: Exploring the efficacy of CAR-T and cancer vaccines","year":2025,"lang":"en","type":"review","venue":"Experimental Hematology and Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"National University Health System","keywords":"Cancer immunotherapy; Medicine; Cancer; Immunotherapy; Blood cancer; Immunology; Oncology; Internal medicine","score_opus":0.27417381271174723,"score_gpt":0.4431416177267477,"score_spread":0.16896780501500047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410464105","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010157102,0.98661405,0.0000075631865,0.00020344208,0.00044440056,0.0023244591,0.000015525979,0.000016621998,0.00021683866],"genre_scores_gemma":[0.004501343,0.990563,0.00014953228,0.00010016932,0.00028992587,0.0036596726,0.000053666397,0.000036599467,0.0006461064],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99842525,0.00023786511,0.0005066463,0.00044442626,0.00009153271,0.00029429872],"domain_scores_gemma":[0.99842125,0.0009965148,0.00019957844,0.0002805249,0.000042031497,0.00006011583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024320991,0.0003125739,0.0017645961,0.00016972967,0.00016303669,0.000012963978,0.00013387826,0.0003479216,0.00014884102],"category_scores_gemma":[0.000035086316,0.00020890302,0.00021575879,0.00015425927,0.00032367845,0.000048648308,0.00011142729,0.0003025851,5.493244e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042886933,0.00027750366,0.000050749455,0.009271321,0.001239082,0.000010111783,0.0012392838,3.5834825e-7,0.0020831174,0.002115775,0.000112495094,0.98317134],"study_design_scores_gemma":[0.007085878,0.0025227503,0.000026031847,0.0054531205,0.003429841,0.0013103466,0.0017786052,0.000088262736,0.03141906,0.000032906082,0.9463847,0.0004684933],"about_ca_topic_score_codex":0.00013247837,"about_ca_topic_score_gemma":0.00006507698,"teacher_disagreement_score":0.98270285,"about_ca_system_score_codex":0.0002192761,"about_ca_system_score_gemma":0.00078692444,"threshold_uncertainty_score":0.85188174},"labels":[],"label_agreement":null},{"id":"W4410923614","doi":"10.1186/s40164-025-00671-2","title":"Correction: IL‑6‑mediated tumorigenicity and antioxidant state in squamous cell carcinoma cells are driven by CD109 via stabilization of IL‑6 receptor‑alpha and activation of STAT3/NRF2 pathway","year":2025,"lang":"en","type":"erratum","venue":"Experimental Hematology and Oncology","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; McGill University; McGill University Health Centre","funders":"","keywords":"Cancer research; Alpha (finance); Antioxidant; Basal cell; STAT3; Receptor; Chemistry; Signal transduction; Cell biology; Biology; Internal medicine; Medicine; Biochemistry","score_opus":0.005733744149326284,"score_gpt":0.2424525232188258,"score_spread":0.2367187790694995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410923614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98726124,0.008826535,0.00025279002,0.000032946715,0.0020787232,0.00052463723,0.0005648176,0.000007963195,0.00045037112],"genre_scores_gemma":[0.99545187,0.0015128991,0.00014706755,0.00006490063,0.00006780287,0.000052323972,0.00128304,0.000027513826,0.0013925598],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99798816,0.00028030958,0.0006522843,0.00069198554,0.00009645554,0.00029081156],"domain_scores_gemma":[0.998748,0.0001270539,0.00067956327,0.00022045859,0.0001305355,0.00009438951],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013179521,0.00036148162,0.00085603556,0.00014730563,0.000071094524,0.0000067571855,0.00012449142,0.000810318,0.000016063208],"category_scores_gemma":[0.00006142156,0.0003882452,0.00006031568,0.0001073208,0.00058272266,0.000012472814,0.00022510956,0.0003513406,4.7477715e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060567056,0.0009563101,0.008048136,0.00045706108,0.000039216957,0.000006200456,0.00080876006,0.0000024315452,0.9641881,0.000012496534,0.02465488,0.00022076553],"study_design_scores_gemma":[0.0025728561,0.0011964779,0.001731342,0.000067973415,0.000022649121,0.000019036497,0.0012414884,0.000097028926,0.9870486,0.00004184948,0.005662195,0.00029845996],"about_ca_topic_score_codex":0.00019339283,"about_ca_topic_score_gemma":0.00018610895,"teacher_disagreement_score":0.022860574,"about_ca_system_score_codex":0.00009135264,"about_ca_system_score_gemma":0.0002396623,"threshold_uncertainty_score":0.99985695},"labels":[],"label_agreement":null}]}